CA
VRTX icon

Cache Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Cache Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-231
Closed -$103K – 205
2026
Q1 		$103K Buy
+231
New +$108K 0.01% 142

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Cache Advisors's VRTX Position: Q2 2026 in Review

Cache Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 231 shares — an estimated $103K sold.

Cache Advisors first reported a position in VRTX in Q1 2026 and held it in 1 quarter. The position peaked at $103K in Q1 2026. 368 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Cache Advisors reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Cache Advisors sold 231 Vertex Pharmaceuticals shares in Q2 2026, an estimated $103K.
  • Cache Advisors first reported a position in Vertex Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Cache Advisors's Vertex Pharmaceuticals position peaked at $103K in Q1 2026.
  • 368 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Cache Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.